Skip to main content

Press Releases

January 4, 2018

Washington, DC – Congresswoman Diana DeGette (D-CO), Chief Deputy Whip, said if the Justice Department urges federal prosecutors to more aggressively enforce marijuana laws in states such as Colorado that have legalized sales of the drug, it will undermine people's rights and jeopardize an important industry.

December 22, 2017

Washington, DC – Congresswoman Diana DeGette (D-CO), author of a bill promoting energy conservation and encouraging innovations in LED lighting that passes the House in January, hailed last night's Senate passage of the bill and anticipated that it would be signed into law soon.

December 22, 2017

Washington, DC – The co-chairs of the Congressional Pro-Choice Caucus, Diana DeGette (D-CO) and Louise Slaughter (D-NY), today called on the leadership of the House Judiciary Committee to subpoena Department of Health and Human Services (HHS) officials involved in a decision to deny a 17-year-old rape victim her right to have an abortion.

December 20, 2017

WASHINGTON, DCFunding for cost-sharing reductions (CSRs) to help lower-income people pay for health care may be included in the continuing resolution on which both houses of Congress must vote in order to keep the government operating.

If this funding is included in the bill, House Republicans are demanding a provision that would keep health insurance plans from receiving CSR funds through the Affordable Care Act if they cover abortion services. As a result, countless women could be deprived of access to abortion via health insurance in the private market.

December 15, 2017

Denver – Congresswoman Diana DeGette (D-CO), a senior member of the House Energy and Commerce Committee, today said she would co-sponsor a congressional effort to restore Net Neutrality protections that were rolled back yesterday in a party-line vote by the Federal Communications Commission. DeGette supports a resolution to be introduced by Congressman Mike Doyle (D-PA), the ranking member on the Subcommittee on Communications and Technology, reversing the FCC's new regulations.

December 8, 2017

Washington, DC – Nearly 100 members of Congress, led by Representatives Diana DeGette (D-CO), André Carson (D-IN) and Beto O'Rourke (D-TX), today sent letters to top House and Senate leaders on both sides of the aisle urging bipartisan cooperation in finding a way to responsibly extend funding for the Children's Health Insurance Program, which was allowed to lapse on September 30.

December 8, 2017

Today, Diana DeGette, Co-Chair of the Congressional Pro-Choice Caucus, and Rep. Jan Schakowksy, Ranking Member of the Republican now dissolved Select Panel, released the following statement after media reported that the Department of Justice sent a letter to the Senate Judiciary Committee inquiring about the Committee's report on fetal tissue:

December 6, 2017

Washington, DC – Congresswoman Diana DeGette (D-CO), Chief Deputy Whip, issued the following statement about the privileged resolution introduced today:

"Special Counsel Robert Mueller's investigation is proceeding and has already produced important results. I'm watching to see what further evidence of wrongdoing it uncovers, including the possibility of impeachable offenses. In the meantime, House consideration of this resolution is premature."

December 6, 2017

Washington, DC – Congresswoman Diana DeGette (D-CO), Chief Deputy Whip, said she voted against the Concealed Carry Reciprocity Act (H.R. 38) today because it would weaken standards for public safety in many states, including Colorado.

"This bill gives the weakest state standards on gun violence prevention the force of law nationwide," DeGette said. "Compelling state legislatures to adopt the concealed carry standards of other states will only undermine the protections that their citizens have come to expect their elected officials to uphold.

November 9, 2017

Washington, DC –Rep. Diana DeGette (D-CO) and her Diabetes Caucus co-chair, Rep. Tom Reed (R-NY), have released a bipartisan request for stakeholders to provide information about whether health plans can pay for insulin based on how well the particular drug product works for patients.